PT - JOURNAL ARTICLE AU - Rachelle N. Binny AU - Michael G. Baker AU - Shaun C. Hendy AU - Alex James AU - Audrey Lustig AU - Michael J. Plank AU - Kannan M. Ridings AU - Nicholas Steyn TI - Early intervention is the key to success in COVID-19 control AID - 10.1101/2020.10.20.20216457 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.20.20216457 4099 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216457.short 4100 - http://medrxiv.org/content/early/2020/10/23/2020.10.20.20216457.full AB - New Zealand responded to the COVID-19 pandemic with a combination of border restrictions and an Alert Level system that included strict stay-at-home orders. These interventions were successful in containing the outbreak and ultimately eliminating community transmission of COVID-19. The timing of interventions is crucial to their success. Delaying interventions for too long may both reduce their effectiveness and mean that they need to be maintained for a longer period of time. Here, we use a stochastic branching process model of COVID-19 transmission and control to simulate the epidemic trajectory in New Zealand and the effect of its interventions during its COVID-19 outbreak in March-April 2020. We use the model to calculate key outcomes, including the peak load on the contact tracing system, the total number of reported COVID-19 cases and deaths, and the probability of elimination within a specified time frame. We investigate the sensitivity of these outcomes to variations in the timing of the interventions. We find that a delay to the introduction of Alert Level 4 controls results in considerably worse outcomes. Changes in the timing of border measures have a smaller effect. We conclude that the rapid response in introducing stay-at-home orders was crucial in reducing the number of cases and deaths and increasing the probability of elimination.Executive SummaryEvaluating the effectiveness of New Zealand’s COVID-19 response, relative to hypothetical response scenarios, is important for guiding future response strategies. We assess the importance of early implementation of interventions for controlling COVID-19.We model counterfactual (alternative ‘what-if’) scenarios in which the timings of three policy interventions are varied: border restrictions requiring 14-day quarantine of all international arrivals, border closure except to returning residents and citizens, and Alert Level 4 restrictions.Key measures describing the dynamics of a COVID-19 outbreak (notably peak load on the contact tracing system, the total number of reported COVID-19 cases and deaths, and the probability of elimination within a specified time frame), are used to compare outcomes from each scenario with New Zealand’s actual outcomes.Key measures were more sensitive to the timing of Alert Level 4, than to timing of border restrictions and border closure. Of the three counterfactual scenarios, an earlier start to Alert Level 4 would have resulted in the greatest reduction in numbers of cases and deaths.Delaying the start of Alert Level 4 by 20 days could have led to over 11,500 cases and 200 deaths, and would have substantially reduced the probability of eliminating community transmission of COVID-19, requring a longer period at Alert Level 4 to achieve control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Ministry of Business, Innovation and Employment and Te ūnaha Matatini, New Zealand's Centre of Research Excellence in complex systems.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval or exemption for this research was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be obtained for research purposes by contacting data-enquiries@health.govt.nz and following the COVID-19 data request process.